JP2020529847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529847A5 JP2020529847A5 JP2020505464A JP2020505464A JP2020529847A5 JP 2020529847 A5 JP2020529847 A5 JP 2020529847A5 JP 2020505464 A JP2020505464 A JP 2020505464A JP 2020505464 A JP2020505464 A JP 2020505464A JP 2020529847 A5 JP2020529847 A5 JP 2020529847A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- immune cells
- types
- cells
- lymphocytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762540901P | 2017-08-03 | 2017-08-03 | |
| US62/540,901 | 2017-08-03 | ||
| PCT/US2018/044740 WO2019028098A1 (en) | 2017-08-03 | 2018-08-01 | METHODS AND COMPOSITIONS FOR TREATING CANCER |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529847A JP2020529847A (ja) | 2020-10-15 |
| JP2020529847A5 true JP2020529847A5 (cg-RX-API-DMAC7.html) | 2021-09-09 |
Family
ID=65234162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505464A Pending JP2020529847A (ja) | 2017-08-03 | 2018-08-01 | がんの処置のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200155600A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3661953A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2020529847A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20200036874A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111094328A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018308982A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3071448A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL272147A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202000724XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019028098A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3952909A4 (en) * | 2019-04-08 | 2023-06-07 | Taiga Biotechnologies, Inc. | COMPOSITIONS AND METHODS FOR CRYOPRESERVING IMMUNE CELLS |
| SG11202112529WA (en) * | 2019-05-14 | 2021-12-30 | Taiga Biotechnologies Inc | Compositions and methods for treating t cell exhaustion |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6358739B1 (en) * | 1999-04-12 | 2002-03-19 | Modex Therapeutiques, S.A. | Transiently immortalized cells |
| US20040241140A1 (en) * | 2000-11-01 | 2004-12-02 | Pavlakis George N. | Expression vectors able to elicit improved immune response and methods of using same |
| AU2003216288B2 (en) * | 2002-02-13 | 2009-09-24 | Duke University | Modulation of immune response by non-peptide binding stress response polypeptides |
| US20060222657A1 (en) * | 2003-06-20 | 2006-10-05 | Dowdy Steven F | Polypeptide transduction and fusogenic peptides |
| US8883507B2 (en) * | 2005-10-18 | 2014-11-11 | The Regents Of The University Of Colorado | Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells |
| US8784825B2 (en) * | 2008-08-28 | 2014-07-22 | Taiga Biotechnologies, Inc. | Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC |
| JP6285930B2 (ja) * | 2012-07-20 | 2018-02-28 | タイガ バイオテクノロジーズ,インク. | 造血コンパートメントの再構築及び自家再構築の増進 |
| US9365825B2 (en) * | 2013-03-11 | 2016-06-14 | Taiga Biotechnologies, Inc. | Expansion of adult stem cells in vitro |
| EP3461491B1 (en) * | 2013-04-18 | 2024-11-13 | TILT Biotherapeutics Oy | Enhanced adoptive cell therapy |
| US10149898B2 (en) * | 2017-08-03 | 2018-12-11 | Taiga Biotechnologies, Inc. | Methods and compositions for the treatment of melanoma |
| EP4026554A1 (en) * | 2017-08-03 | 2022-07-13 | Taiga Biotechnologies, Inc. | Methods and compositions for the treatment of melanoma |
-
2018
- 2018-08-01 EP EP18841366.0A patent/EP3661953A4/en not_active Withdrawn
- 2018-08-01 JP JP2020505464A patent/JP2020529847A/ja active Pending
- 2018-08-01 WO PCT/US2018/044740 patent/WO2019028098A1/en not_active Ceased
- 2018-08-01 KR KR1020207004465A patent/KR20200036874A/ko not_active Ceased
- 2018-08-01 CN CN201880057363.5A patent/CN111094328A/zh active Pending
- 2018-08-01 US US16/635,383 patent/US20200155600A1/en not_active Abandoned
- 2018-08-01 CA CA3071448A patent/CA3071448A1/en active Pending
- 2018-08-01 SG SG11202000724XA patent/SG11202000724XA/en unknown
- 2018-08-01 AU AU2018308982A patent/AU2018308982A1/en not_active Abandoned
-
2020
- 2020-01-20 IL IL272147A patent/IL272147A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3037919T3 (en) | Mage a4 t cell receptors | |
| TWI822726B (zh) | Nyeso t細胞受體 | |
| US20220098300A1 (en) | Anti trbc1 antigen binding domains | |
| Kiesgen et al. | Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies | |
| JP2021058197A5 (cg-RX-API-DMAC7.html) | ||
| JP2024074801A5 (cg-RX-API-DMAC7.html) | ||
| CN118546959A (zh) | Cd19定向性嵌合抗原受体及其在免疫疗法中的用途 | |
| JP7227630B2 (ja) | Y182t突然変異を有するt細胞-抗原カプラおよびその方法ならびに使用 | |
| JP2020517259A5 (cg-RX-API-DMAC7.html) | ||
| JP2022512541A5 (cg-RX-API-DMAC7.html) | ||
| TW201619377A (zh) | Car表現載體及car表現t細胞 | |
| JP2019534246A5 (cg-RX-API-DMAC7.html) | ||
| WO2021048724A1 (en) | Combined expression of a chimeric cd3 fusion protein and an anti-cd3-based bispecific t cell activating element | |
| Franks et al. | New anticancer immunotherapies | |
| IL301995A (en) | Cells comprising t cell-antigen couplers and uses thereof | |
| JP2021512637A5 (cg-RX-API-DMAC7.html) | ||
| CN110114057A (zh) | Tlr9激动剂对癌症治疗的免疫调节作用 | |
| JP2021525068A5 (cg-RX-API-DMAC7.html) | ||
| Long et al. | HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice | |
| CN115023237A (zh) | 癌症或肿瘤的治疗方法 | |
| JP2022547809A5 (cg-RX-API-DMAC7.html) | ||
| WO2022033483A1 (zh) | 多功能的免疫效应细胞及其应用 | |
| EP4367141A1 (en) | Gpc3 t cell-antigen couplers and uses thereof | |
| US12479903B2 (en) | CD5 specific T cell receptor cell or gene therapy | |
| JP2022503621A5 (cg-RX-API-DMAC7.html) |